Skip to content

Clinical trials

Completed Phase 2/3 Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 2/3 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20041
20061
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AHS Cancer Control Alberta1
Children's Oncology Group1
Erasme University Hospital1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
French Innovative Leukemia Organisation1
Lymphoma Study Association1
Roswell Park Cancer Institute1
University College, London1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma9
Leukemia3
Myelodysplastic Syndromes3
Anemia, Refractory2
Anemia, Refractory, with Excess of Blasts2
Leukemia, Biphenotypic, Acute2
Leukemia, Myeloid, Accelerated Phase2
Leukemia, Myeloid, Acute2
Leukemia, Myeloid, Chronic-Phase2
Leukemia, Myelomonocytic, Chronic2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.